Urology Guidewires Market Size, Share & Growth Report 2032
Urology Guidewires Market Size, Share & Growth Report 2032
Segments - Urology Guidewires Market by Material (Nitinol Guidewires, Stainless Steel Guidewires, and Hybrid Guidewires), Application (Ureteroscopy (URS), Percutaneous Nephrolithotomy (PCNL), Ureteral Stenting, and Transurethral Resection of the Prostate (TURP)), End-user (Hospitals, Specialty Clinics, Diagnostic Centers), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024 – 2032
Upcoming
| Report ID :HC-6480
| 4.8 Rating
| 90 Reviews
| 231 Pages
| Format :
Report Description
Urology Guidewires Market Outlook 2032
The global urology guidewires market size was USD 3.5 Billion in 2023 and is likely to reach USD 6.2 Billion by 2032, expanding at a CAGR of 6.6% during 2024–2032. The market growth is attributed to the increasing adoption of minimally invasive procedure.
Urology guidewires are thin, flexible wires used by urologists during minimally invasive procedures to navigate the urinary tract. They act as a guide for inserting other medical instruments such as catheters, ureteral stents, and scopes. Nitinol's shape memory and super elasticity make it ideal for navigating the complex urinary tract. This material is becoming increasingly popular, thus driving the market.
The next-gen hybrid guidewires combine nitinol with other materials such as stainless steel to offer a balance between flexibility, affordability, and specific functionalities for certain procedures. AI and advanced manufacturing techniques are being used to design guidewires with improved functionalities, such as enhanced flexibility for intricate anatomical pathways, superior compatibility with other medical devices used in urology, and biocompatible coatings to minimize infection risk.
Impact of Artificial Intelligence (AI) in Urology Guidewires Market
Improved guidewires with AI for enhanced flexibility and navigation, improved compatibility, and material optimization driving the global market. Moreover, the increasing precision and reduced risks of complications by using robotic assisted procedures, which is expected to propel the market during the forecast period.
AI integration in the urology guidewires market holds a promising future for its innovation, procedural efficiency, and patient care is expected to boost the market in the coming years. AI is evolving its application in medical devices and its potential to revolutionize the urology guidewires market.
Urology Guidewires Market Dynamics
Major Drivers
Increasing adoption of minimally invasive procedures is driving the global market. Moreover, increasing number of product launch is expected to propel the market during the forecast period.
-
For instance, in June 2023, Teleflex Incorporated launched Wattson Temporary Pacing Guidewire, designed for using Balloon Aortic Valvuloplasty (BAV) and Transcatheter Aortic Valve Replacement (TAVR). The guidewire offers supporting valve delivery, dual functionality, and ventricular bipolar pacing. It aims to improve procedural efficiencies and reduce complications associated with traditional methods.
Existing Restraints
High costs of the procedure are hindering the global market. Nitinol, the most preferred material for its superior properties, is a relatively costly material. This can translate to higher costs for guidewires than traditional options such as stainless steel. This creates a barrier for some healthcare institutions, especially in cost-sensitive settings.
Emerging Opportunities
Use of advanced materials and coatings such as hydrophilic coatings, is expected to improve its performance and reduce the risk of complications. Additionally, the electromagnetic navigation systems for developing guidewires guided by electromagnetic fields and magnetic resonance imaging (MRI)-compatible guidewires is expected to propel the market during the forecast period.
Scope of the Urology Guidewires Market Report
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Urology Guidewires Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2023 |
|
Historic Data |
2017–2022 |
|
Forecast Period |
2024–2032 |
|
Segmentation |
Material (Nitinol Guidewires, Stainless Steel Guidewires, and Hybrid Guidewires), Application [Ureteroscopy (URS), Percutaneous Nephrolithotomy (PCNL), Ureteral Stenting, and Transurethral Resection of the Prostate (TURP)], and End-user (Hospitals, Specialty Clinics, Diagnostic Centers), |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Abbott Laboratories B. Braun Melsungen AG; Boston Scientific Corporation; Coloplast A/S; Cook Medical; Ferring Pharmaceuticals; Medtronic plc; Olympus Corporation; Rigicon, Inc; Teleflex Incorporated; and William Cook Europe |
Market Segment Insights
Regional Analysis
In terms of region, the global urology guidewires market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the global market in 2023 owing to the rising prevalence of chronic diseases such as chronic kidney diseases (CKD) and urological disorders. Increasing number of urologist population is driving the regional market. For instance,
-
In 2021, the the American Urological Association (AUA) registered the total urologist population was 13,352 who were practicing. An increase of 2.4% from 13,044 practicing urologists in 2019.
Increasing demand for well-established procedures that are minimally invasive in nature is propelling the regional market.
The market in Asia Pacific is projected to grow at a significant pace in the coming years owing to the rising in population suffering from kidney & cardiovascular diseases. Furthermore, improvements in medical facilities and availability of insurance policies are driving the regional market. Increasing number of patient population and rising technological advancements are fueling the regional market.
Segment Analysis
Material Segment Analysis
Based on material, the urology guidewires market is divided into nitinol guidewires, stainless steel guidewires, and hybrid guidewires. The nitinol guidewires segment held the largest share of the global market in 2023 owing to its shape memory. Nitinol, after the deformation, returns to its original shape when exposed to a specific temperature allowing urologists to navigate the complex anatomy of the urinary tract, thus driving the segment. Furthermore, its super elasticity makes it ideal for procedures requiring a lot of manipulation of the guidewires.
The stainless-steel guidewires segment is anticipated to expand at a substantial CAGR during the forecast period due to its cost-effectiveness. Stainless steel is a cheaper material than nitinol. This factor becomes crucial for certain procedures or in cost-sensitive healthcare settings. Moreover, the adequate performance for some applications and established technology with long history in medical devices is boosting the segment.
Application Segment Analysis
On the basis of application, the global market is segregated into ureteroscopy (URS), percutaneous nephrolithotomy (PCNL), ureteral stenting, and transurethral resection of the prostate (TURP). The ureteroscopy (URS) segment is anticipated to expand at a considerable CAGR during the forecast period owing to it being a minimally invasive procedure. Increasing adoption of URS in diagnosing and treating conditions in ureters due to its advantages over traditional surgery, which is boosting the segment.
The transurethral resection of the prostate (TURP) segment is projected to register robust growth during the assessment years owing to it being the most well-established surgical procedure for enlarged prostrate, which is propelling the segment. Moreover, increasing number of guidewires, used annually for TURP, is expected to drive the segment during the forecast period.
End-user Segment Analysis
On the basis of end-user, the urology guidewires market is segmented into hospitals, specialty clinics, and diagnostic centers. The hospitals segment held a key share of the market in 2023 owing to the high volume of urological procedures. Hospitals generally handle a wider range of urological procedures than specialty clinics or diagnostic centers. This translates to a high demand for guidewires to support these procedures. Furthermore, the complex procedures and emergency preparedness for a broad spectrum of urological disorders is fueling the segment.
The specialty clinics segment is expected to expand at a significant pace during the projection period due to a focus on specific procedures. These clinics cater to specific urological conditions, potentially leading to a high volume of procedures that utilize guidewires relevant to their area of expertise. Additionally, the technological advancements, high efficiency, and convenience is fueling the segment.
Segments
The urology guidewires market has been segmented on the basis of
Material
- Nitinol Guidewires
- Stainless Steel Guidewires
- Hybrid Guidewires
Application
- Ureteroscopy (URS)
- Percutaneous Nephrolithotomy (PCNL)
- Ureteral Stenting, and Transurethral Resection of the Prostate (TURP)
End-user
- Hospitals
- Specialty Clinics
- Diagnostic Centers
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Abbott Laboratories
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Coloplast A/S
- Cook Medical
- Ferring Pharmaceuticals
- Medtronic plc
- Olympus Corporation
- Rigicon Inc
- Teleflex Incorporated
- William Cook Europe
Competitive Landscape
Key players competing in the global urology guidewires market are Abbott Laboratories B. Braun Melsungen AG; Boston Scientific Corporation; Coloplast A/S; Cook Medical; Ferring Pharmaceuticals; Medtronic plc; Olympus Corporation; Rigicon, Inc; Teleflex Incorporated; and William Cook Europe.
-
In April 2022, Ferring Pharmaceuticals launched a facility in Hyderabad, India, for the development and manufacturing of urology products in India.
-
In 2020, Rigicon, Inc. launched its malleable implant in India. The implant offers physicians a malleable penile prosthesis that is easy to size, extend, and implant.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Urology Guidewires Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Urology Guidewires Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Urology Guidewires Market - Supply Chain
4.5. Global Urology Guidewires Market Forecast
4.5.1. Urology Guidewires Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Urology Guidewires Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Urology Guidewires Market Absolute $ Opportunity
5. Global Urology Guidewires Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Urology Guidewires Market Size and Volume Forecast by Applications
5.3.1. Ureteroscopy (URS)
5.3.2. Percutaneous Nephrolithotomy (PCNL)
5.3.3. Ureteral Stenting, and Transurethral Resection of the Prostate (TURP)
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Urology Guidewires Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Urology Guidewires Market Size and Volume Forecast by End Users
6.3.1. Hospitals
6.3.2. Specialty Clinics
6.3.3. Diagnostic Centers
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Urology Guidewires Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Urology Guidewires Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Urology Guidewires Demand Share Forecast, 2019-2026
8. North America Urology Guidewires Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Urology Guidewires Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Urology Guidewires Market Size and Volume Forecast by Applications
8.4.1. Ureteroscopy (URS)
8.4.2. Percutaneous Nephrolithotomy (PCNL)
8.4.3. Ureteral Stenting, and Transurethral Resection of the Prostate (TURP)
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Urology Guidewires Market Size and Volume Forecast by End Users
8.7.1. Hospitals
8.7.2. Specialty Clinics
8.7.3. Diagnostic Centers
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Urology Guidewires Demand Share Forecast, 2019-2026
9. Latin America Urology Guidewires Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Urology Guidewires Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Urology Guidewires Market Size and Volume Forecast by Applications
9.4.1. Ureteroscopy (URS)
9.4.2. Percutaneous Nephrolithotomy (PCNL)
9.4.3. Ureteral Stenting, and Transurethral Resection of the Prostate (TURP)
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Urology Guidewires Market Size and Volume Forecast by End Users
9.7.1. Hospitals
9.7.2. Specialty Clinics
9.7.3. Diagnostic Centers
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Urology Guidewires Demand Share Forecast, 2019-2026
10. Europe Urology Guidewires Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Urology Guidewires Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Urology Guidewires Market Size and Volume Forecast by Applications
10.4.1. Ureteroscopy (URS)
10.4.2. Percutaneous Nephrolithotomy (PCNL)
10.4.3. Ureteral Stenting, and Transurethral Resection of the Prostate (TURP)
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Urology Guidewires Market Size and Volume Forecast by End Users
10.7.1. Hospitals
10.7.2. Specialty Clinics
10.7.3. Diagnostic Centers
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Urology Guidewires Demand Share Forecast, 2019-2026
11. Asia Pacific Urology Guidewires Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Urology Guidewires Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Urology Guidewires Market Size and Volume Forecast by Applications
11.4.1. Ureteroscopy (URS)
11.4.2. Percutaneous Nephrolithotomy (PCNL)
11.4.3. Ureteral Stenting, and Transurethral Resection of the Prostate (TURP)
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Urology Guidewires Market Size and Volume Forecast by End Users
11.7.1. Hospitals
11.7.2. Specialty Clinics
11.7.3. Diagnostic Centers
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Urology Guidewires Demand Share Forecast, 2019-2026
12. Middle East & Africa Urology Guidewires Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Urology Guidewires Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Urology Guidewires Market Size and Volume Forecast by Applications
12.4.1. Ureteroscopy (URS)
12.4.2. Percutaneous Nephrolithotomy (PCNL)
12.4.3. Ureteral Stenting, and Transurethral Resection of the Prostate (TURP)
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Urology Guidewires Market Size and Volume Forecast by End Users
12.7.1. Hospitals
12.7.2. Specialty Clinics
12.7.3. Diagnostic Centers
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Urology Guidewires Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Urology Guidewires Market: Market Share Analysis
13.2. Urology Guidewires Distributors and Customers
13.3. Urology Guidewires Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Abbott Laboratories
13.4.2. B. Braun Melsungen AG
13.4.3. Boston Scientific Corporation
13.4.4. Coloplast A/S
13.4.5. Cook Medical
13.4.6. Ferring Pharmaceuticals
13.4.7. Medtronic plc
13.4.8. Olympus Corporation
13.4.9. Rigicon Inc
13.4.10. Teleflex Incorporated
13.4.11. William Cook Europe
Methodology
Related Reports
Some other reports from this category!
Our Clients
